CSPC 2019 has ended
Back To Schedule
Wednesday, November 13 • 4:15pm - 5:30pm
Ontario-First in the innovation economy: impacts of a $1B public-private-partnership on Canadian healthcare commercialization / L'Ontario d'abord au sein de l'économie de l'innovation : répercussions d'un partenariat de 1 milliard de dollars entr

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Panel Organized by: FACIT 

FACIT, an Ontario business accelerator focused on oncology innovations, and its strategic partner, the Ontario Institute for Cancer Research (OICR), have laid the foundation for an innovation commercialization pathway through public-private-partnerships (PPPs). In early 2019, FACIT and one of its portfolio companies, Triphase Accelerator, announced a historic $1B USD partnership with Celgene for an OICR-discovered blood cancer therapy. This transaction demonstrates the realization of a “discovered and developed” commercialization pathway created by Ontario partners over the last decade. The panel will discuss how this pathway came to fruition and illustrate the importance of PPPs to generate meaningful innovation outcomes.

avatar for Christine Williams

Christine Williams

Deputy Director, Ontario Institute for Cancer Research
Dr. Christine Williams is Deputy Director of the Ontario Institute for Cancer Research (OICR), which both performs and enables collaborative cancer research to have global patient impact and bring economic benefit to Ontario. Dr. Williams works with OICR’s executive team and scientific... Read More →

avatar for Grant Gibson

Grant Gibson

Chief Financial Officer, Triphase Accelerator
Grant Gibson joined Triphase in 2012 and has more than 20 years of experience focused on the biotech, pharma and life science industries, with expertise in corporate strategy, M&A, finance and operations. Throughout his career Grant has led several strategic and operational endeavours... Read More →
avatar for Rima Al-awar

Rima Al-awar

Director and Senior Principal Investigator, Drug Discovery Program, Ontario Institute for Cancer Research
Dr. Rima Al-awar earned a PhD in synthetic organic chemistry from North Carolina State University and completed a postdoctoral fellowship at the University of North Carolina at Chapel Hill prior to joining Eli Lilly and Company in 1995. In 2002, while still at Eli Lilly, Dr. Al-awar... Read More →
avatar for Kevin Leshuk

Kevin Leshuk

Vice President & General Manager, Celgene Canada
Kevin Leshuk, a graduate of McMaster University, Hamilton, Ontario, began his career in the pharmaceutical/biotech industry in the early 1990’s working with Adria Oncology. As the first and current Vice President and General Manager for Celgene Inc, the Canadian affiliate of Celgene... Read More →
avatar for David O’Neill

David O’Neill

President, FACIT
David O’Neill brings extensive experience in Pharma, Biotech and seed stage investing to his role as President of FACIT.  Dr. O’Neill has a wealth of networks and transaction experience through various business development roles at AstraZeneca, Ambit Biosciences (Daiichi Sankyo... Read More →

Wednesday November 13, 2019 4:15pm - 5:30pm EST
Governor General II